GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout – HBSS

by

Investors who lost money in GRAL after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Source: globenewswire

Country: United States